GAMMA Investing LLC Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

GAMMA Investing LLC grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 388.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 1,930 shares of the medical device company’s stock after acquiring an additional 1,535 shares during the period. GAMMA Investing LLC’s holdings in Cooper Companies were worth $196,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Cooper Companies by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 5,732,473 shares of the medical device company’s stock valued at $2,169,397,000 after acquiring an additional 56,911 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Cooper Companies by 4.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,627,596 shares of the medical device company’s stock valued at $517,592,000 after acquiring an additional 62,345 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Cooper Companies by 16.5% in the 4th quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after buying an additional 140,700 shares in the last quarter. Norges Bank bought a new stake in Cooper Companies in the 4th quarter worth about $196,045,000. Finally, Northern Trust Corp increased its holdings in Cooper Companies by 3.4% in the 3rd quarter. Northern Trust Corp now owns 510,353 shares of the medical device company’s stock worth $162,297,000 after buying an additional 16,571 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Up 0.1 %

COO stock opened at $91.73 on Friday. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $104.07. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34. The stock has a market cap of $18.27 billion, a P/E ratio of 53.88, a PEG ratio of 2.27 and a beta of 1.02. The business’s 50-day moving average price is $93.08 and its 200-day moving average price is $94.58.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million for the quarter, compared to analysts’ expectations of $948.07 million. During the same period in the previous year, the firm earned $0.77 EPS. The business’s quarterly revenue was up 7.4% on a year-over-year basis. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on COO shares. Citigroup lifted their price objective on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. TheStreet downgraded Cooper Companies from a “b-” rating to a “c” rating in a report on Thursday, February 29th. JPMorgan Chase & Co. upgraded Cooper Companies from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. Piper Sandler lifted their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, March 1st. Finally, Mizuho boosted their price target on Cooper Companies from $102.50 to $115.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $111.42.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.